Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872558 · ClinicalTrials.gov registry record · NA
Shared Decision Making in Parents of Children With Acute Otitis Media
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT02872558: Completed NA study, sponsored by Mayo Clinic.
NCT02872558 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02872558, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of shared decision making in treatment of Acute Otitis Media in the Emergency Department setting.
Interventions
- OTHER Usual Care
- OTHER Acute Otitis Media Choice Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2017-03-26 |
| Est. Completion | 2019-06-15 |
| Phase | NA |
What the finished NCT02872558 record still lists
NCT02872558 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02872558 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02872558 about?
NCT02872558 is a clinical study titled "Shared Decision Making in Parents of Children With Acute Otitis Media". This study will evaluate the efficacy of shared decision making in treatment of Acute Otitis Media in the Emergency Department setting.
What is the current status of trial NCT02872558?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2017-03-26. Estimated completion is 2019-06-15.
What interventions are being tested in trial NCT02872558?
The interventions under investigation include: Usual Care (OTHER), Acute Otitis Media Choice Decision Aid (OTHER).
Who is sponsoring clinical trial NCT02872558?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02872558's enrollment target sits among peer trials
101 840th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI